1-anilino-8-naphthalenesulfonate has been researched along with liraglutide in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franks, AS; Lee, PH; Stockton, MD | 1 |
| Crnic, T; Drincic, A; Kershaw, S; Knezevich, E | 1 |
| Jelsing, J; Jensen, AE; Knudsen, LB; Simonsen, L; Søeborg, H; Thorup, I; Vrang, N | 1 |
| Nakazato, M; Ueno, H | 1 |
| Baeres, FM; Bergenstal, RM; Buse, JB; Daniels, GH; Mann, JF; Marso, SP; Moses, AC; Nauck, MA; Steen Ravn, L; Steinberg, WM; Stockner, M; Zinman, B | 1 |
| Cobelli, C; Irie, J; Itoh, H; Jinzaki, M; Kawai, T; Manesso, E; Meguro, S; Saisho, Y; Sugiura, H; Tanaka, K; Tanaka, M | 1 |
| Buse, JB; Ghorbani, MLM; Nauck, MA; Steinberg, WM; Ørsted, DD | 1 |
1 review(s) available for 1-anilino-8-naphthalenesulfonate and liraglutide
| Article | Year |
|---|---|
[Cutting-edge of medicine; the prospects of novel anti-obesity drugs].
Topics: Anti-Obesity Agents; Appetite; Appetite Depressants; Benzazepines; Benzoxazines; Bupropion; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Discovery; Energy Metabolism; Enzyme Inhibitors; Fructose; Glucagon-Like Peptide 1; Humans; Hypothalamus; Lactones; Lipase; Liraglutide; Metabolic Syndrome; Naltrexone; Obesity; Orlistat; Phentermine; Topiramate | 2014 |
3 trial(s) available for 1-anilino-8-naphthalenesulfonate and liraglutide
| Article | Year |
|---|---|
LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial.
Topics: Acute Disease; Aged; Amylases; Biomarkers; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Kidney; Lipase; Liraglutide; Male; Middle Aged; Pancreatitis | 2014 |
Effects of Liraglutide Monotherapy on Beta Cell Function and Pancreatic Enzymes Compared with Metformin in Japanese Overweight/Obese Patients with Type 2 Diabetes Mellitus: A Subpopulation Analysis of the KIND-LM Randomized Trial.
Topics: Amylases; Blood Glucose; Body Fat Distribution; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Lipase; Liraglutide; Male; Metformin; Middle Aged; Obesity; Organ Size; Overweight; Radiography; Treatment Outcome | 2015 |
Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial.
Topics: Acute Disease; Amylases; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypoglycemic Agents; Lipase; Liraglutide; Male; Middle Aged; Pancreatitis; Risk Factors | 2017 |
3 other study(ies) available for 1-anilino-8-naphthalenesulfonate and liraglutide
| Article | Year |
|---|---|
Acute pancreatitis associated with liraglutide.
Topics: Acute Disease; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Exenatide; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Lipase; Liraglutide; Middle Aged; Pancreatitis; Peptides; Venoms | 2011 |
Liraglutide-associated acute pancreatitis.
Topics: Acute Disease; Amylases; Diabetes Mellitus, Type 2; Emergency Service, Hospital; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Lipase; Liraglutide; Male; Middle Aged; Pancreatitis | 2012 |
The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis.
Topics: Animals; Blood Glucose; Cell Proliferation; Exenatide; Female; Glucagon-Like Peptide 1; Glycated Hemoglobin; Hypoglycemic Agents; Lipase; Liraglutide; Male; Pancreas; Pancreatic alpha-Amylases; Pancreatitis; Peptides; Rats; Rats, Zucker; Venoms | 2012 |